NEW YORK — Australian molecular diagnostics developer Genetic Technologies said last week that it received a notice that it is out of compliance with the Nasdaq's continued listing requirements and its shares face delisting.
NEW YORK — Australian molecular diagnostics developer Genetic Technologies said last week that it received a notice that it is out of compliance with the Nasdaq's continued listing requirements and its shares face delisting.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.